Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Australia’s Symbion Recommends Acceptance Of Primary Acquisition Offer

This article was originally published in PharmAsia News

Executive Summary

Australia's health care giant, Symbion Health, now recommends its shareholders accept a $2.4 billion acquisition try by Primary Health Care after the buyer said its bid was unconditional. Primary said in an official notice it now has 53.8 percent of Symbion's voting shares. Primary's offer for more shares is expected to close Feb. 21, when the buyers begin considering whether to divest some of Symbion's assets. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC067648

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel